bpc 157 typical daily dose BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Dose Of Bpc 157 And
Description
Finally, with BPC 157 therapy Virchow was reversed, there was a reversal of arterial and venous thrombosis, a common effect that was rapid and sustained [11,12,13,14,15,16,20,22,23,24,25]

A higher number of units can still mean the same amount of active peptide, or even less, if the vial was reconstituted with more bacteriostatic water

So it goes for tesamorelin, ipamorelin, CJC-1295, and TB4

The mechanism by which pentadecapeptide BPC 157 accelerates healing is not clearly understood
